OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Seroprevalence of anti‐SARS‐CoV‐2 antibodies in Africa: A systematic review and meta‐analysis
Master Chisale, Sheena Ramazanu, Saul Eric Mwale, et al.
Reviews in Medical Virology (2021) Vol. 32, Iss. 2
Open Access | Times Cited: 79

Showing 1-25 of 79 citing articles:

SARS-CoV-2 infection in Africa: a systematic review and meta-analysis of standardised seroprevalence studies, from January 2020 to December 2021
Hannah C. Lewis, Harriet Ware, Mairead Whelan, et al.
BMJ Global Health (2022) Vol. 7, Iss. 8, pp. e008793-e008793
Open Access | Times Cited: 126

The COVID-19 pandemic in the African continent
Godfrey Bwire, Alex Riolexus Ario, Patricia Eyu, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 104

SARS-CoV-2 seroprevalence in children worldwide: a systematic review and meta-analysis
Reza Naeimi, Mahdi Sepidarkish, Abolfazl Mollalo, et al.
EClinicalMedicine (2022) Vol. 56, pp. 101786-101786
Open Access | Times Cited: 54

High SARS-CoV-2 Seroprevalence among Healthcare Workers in Bamako, Mali
Anou M. Somboro, Yacouba Cissoko, Issiaka Camara, et al.
Viruses (2022) Vol. 14, Iss. 1, pp. 102-102
Open Access | Times Cited: 29

Seroprevalence and risk factors of COVID-19 in healthcare workers from 11 African countries: a scoping review and appraisal of existing evidence
Sophie Alice Müller, Rebekah Wood, Johanna Hanefeld, et al.
Health Policy and Planning (2021) Vol. 37, Iss. 4, pp. 505-513
Open Access | Times Cited: 38

Epidemiological impact and cost-effectiveness analysis of COVID-19 vaccination in Kenya
Stacey Orangi, John Ojal, Samuel P. C. Brand, et al.
BMJ Global Health (2022) Vol. 7, Iss. 8, pp. e009430-e009430
Open Access | Times Cited: 28

SARS-CoV-2 infection in Africa: A systematic review and meta-analysis of standardised seroprevalence studies, from January 2020 to December 2021
Hannah C. Lewis, Harriet Ware, Mairead Whelan, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 25

An update on lateral flow immunoassay for the rapid detection of SARS-CoV-2 antibodies
Lucia Spicuzza, Davide Campagna, Chiara Di Maria, et al.
AIMS Microbiology (2023) Vol. 9, Iss. 2, pp. 375-401
Open Access | Times Cited: 14

SARS‐CoV‐2 seroprevalence among blood donors in Uganda: 2019–2022
Evan M. Bloch, Dorothy Kyeyune, Jodie L. White, et al.
Transfusion (2023) Vol. 63, Iss. 7, pp. 1354-1365
Open Access | Times Cited: 13

Coronaviruses Are Abundant and Genetically Diverse in West and Central African Bats, including Viruses Closely Related to Human Coronaviruses
Dowbiss Meta Djomsi, Audrey Lacroix, Abdoul Karim Soumah, et al.
Viruses (2023) Vol. 15, Iss. 2, pp. 337-337
Open Access | Times Cited: 11

COVID-19 Vaccination in the WHO African Region: Progress Made in 2022 and Factors Associated
Franck Mboussou, Bridget Farham, Sheillah Nsasiirwe, et al.
Vaccines (2023) Vol. 11, Iss. 5, pp. 1010-1010
Open Access | Times Cited: 11

The Missing Millions: Uncovering the Burden of Covid‐19 Cases and Deaths in the African Region
Tara McKay, Rachel Sullivan Robinson, Serena Musungu, et al.
Population and Development Review (2024) Vol. 50, Iss. 1, pp. 7-58
Open Access | Times Cited: 4

Rapid Increase of Community SARS-CoV-2 Seroprevalence during Second Wave of COVID-19, Yaoundé, Cameroon
Francis Atéba Ndongo, Emilande Guichet, Eric Mimbe, et al.
Emerging infectious diseases (2022) Vol. 28, Iss. 6
Open Access | Times Cited: 19

EVALUATION OF POPULATION-LEVEL IMMUNITY TO SARS-COV-2 ACROSS BULGARIA (END OF 2023)
Kim Ngoc, Iva Trifonova, Teodora Gladnishka, et al.
PROBLEMS of Infectious and Parasitic Diseases (2025) Vol. 52, Iss. 3, pp. 13-18
Open Access

Determinants of SARS-CoV-2 infection across three sentinels sites in Benin during 2021: A multicentric surveillance study
Aurore Atchade, Anges Yadouléton, Marc Fiogbe, et al.
PLOS Global Public Health (2025) Vol. 5, Iss. 2, pp. e0004227-e0004227
Open Access

Post-Omicron SARS-CoV-2 antibody prevalence in Sierra Leone: A cross-sectional, nationally representative, follow-up serosurvey
Smit Chitre, Mohamed Bailor Barrie, Joseph Sam Kanu, et al.
PLOS Global Public Health (2025) Vol. 5, Iss. 4, pp. e0004273-e0004273
Open Access

Sero-prevalence of SARS-CoV-2 antibodies in Ethiopia: Results of the National Population Based Survey, 2021
Geremew Tasew, Saro Abdella, Birra Bejiga, et al.
PLoS ONE (2025) Vol. 20, Iss. 5, pp. e0313791-e0313791
Open Access

Compartmentalised mucosal and blood immunity to SARS-CoV-2 is associated with high seroprevalence before the Delta wave in Africa
Ya Jankey Jagne, Dawda Jobe, Alansana Darboe, et al.
Communications Medicine (2025) Vol. 5, Iss. 1
Open Access

SARS CoV-2 Seroprevalence in Selected States of High and Low Disease Burden in Nigeria
Olatunji Matthew Kolawole, Oyewale Tomori, D. E. Agbonlahor, et al.
JAMA Network Open (2022) Vol. 5, Iss. 10, pp. e2236053-e2236053
Open Access | Times Cited: 15

SeroTracker‐RoB: A decision rule‐based algorithm for reproducible risk of bias assessment of seroprevalence studies
Niklas Bobrovitz, Kim C. Noël, Zihan Li, et al.
Research Synthesis Methods (2023) Vol. 14, Iss. 3, pp. 414-426
Open Access | Times Cited: 9

COVID-19 in 16 West African Countries: An Assessment of the Epidemiology and Genetic Diversity of SARS-CoV-2 after Four Epidemic Waves
Anna Julienne Selbé Ndiaye, Mamadou Beye, Aissatou Sow, et al.
American Journal of Tropical Medicine and Hygiene (2023) Vol. 109, Iss. 4, pp. 861-873
Open Access | Times Cited: 9

Using mortuary and burial data to place COVID-19 in Lusaka, Zambia within a global context
Richard Sheppard, Oliver J. Watson, Rachel Pieciak, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 8

SARS-CoV-2 seroprevalence and associated risk factors in periurban Zambia: a population-based study
Kwame Shanaube, Ab Schaap, Eveline Klinkenberg, et al.
International Journal of Infectious Diseases (2022) Vol. 118, pp. 256-263
Open Access | Times Cited: 14

High and Rapid Increase in Seroprevalence for SARS-CoV-2 in Conakry, Guinea: Results From 3 Successive Cross-Sectional Surveys (ANRS COV16-ARIACOV)
Abou Aissata Soumah, Mamadou Saliou Kalifa Diallo, Emilande Guichet, et al.
Open Forum Infectious Diseases (2022) Vol. 9, Iss. 5
Open Access | Times Cited: 12

Page 1 - Next Page

Scroll to top